接受放射治疗的头颈癌患者颌骨放射性骨坏死的预防与管理:ISOO-MASCC-ASCO指南
该指南由ISOO-MASCC与ASCO召集多学科专家组制定,检索2009年1月1日至2023年12月1日发表的随机对照试验和观察性研究,并纳入ISOO-MASCC的系统评价。共评估80篇文献,针对头颈放疗后颌骨放射性骨坏死的预防和管理提出推荐;部分推荐基于非正式共识,预防最佳实践和手术管理获强证据支持。
要点
- 预防最佳实践和手术管理方面的推荐被专家组视为有强证据支持。
- 不推荐使用富白细胞和血小板纤维蛋白或光生物调节预防ORN,因证据不足无法形成推荐。
- 高压氧用于预防和管理ORN大多缺乏正当性,支持其应用的证据有限。
核心结论
- 指南针对头颈放疗后颌骨放射性骨坏死的预防和管理提供循证推荐,部分推荐因证据局限基于非正式共识。
研究设计与样本
- ISOO-MASCC与ASCO召集多学科专家组制定指南,检索PubMed、EMBASE和Cochrane Library数据库2009年1月1日至2023年12月1日发表的随机对照试验和观察性研究。
- 指南还纳入ISOO-MASCC进行的系统评价,该系统评价包含1990年1月1日至2008年12月31日发表的研究。
主要发现
- 最初共识别1539篇文献,去除487篇重复文献后,对1052篇研究进行摘要筛选,对104篇进行全文筛选,最终纳入80篇进行系统评价评估。
关键数值与推荐
- 专家组认为有强证据支持的推荐涉及ORN预防的最佳实践和手术管理。
- 对于使用富白细胞和血小板纤维蛋白或光生物调节预防ORN,无法形成推荐。
- 高压氧用于ORN的预防和管理大多缺乏正当性,支持其应用的证据有限。
临床怎么用
- 原文未据此给出推荐。
局限性
- 由于现有证据的局限性,指南的部分推荐依赖于非正式共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide evidence-based recommendations for prevention and management of osteoradionecrosis (ORN) of the jaw secondary to head and neck radiation therapy in patients with cancer. METHODS: The International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer (ISOO-MASCC) and ASCO convened a multidisciplinary Expert Panel to evaluate the evidence and formulate recommendations. PubMed, EMBASE, and Cochrane Library databases were searched for randomized controlled trials and observational studies, published between January 1, 2009, and December 1, 2023. The guideline also incorporated systematic reviews conducted by ISOO-MASCC, which included studies published from January 1, 1990, through December 31, 2008. RESULTS: A total of 1,539 publications were initially identified. There were 487 duplicate publications, resulting in 1,052 studies screened by abstract, 104 screened by full text, and 80 included for systematic review evaluation. RECOMMENDATIONS: Due to limitations of available evidence, the guideline relied on informal consensus for some recommendations. Recommendations that were deemed evidence-based with strong evidence by the Expert Panel were those pertaining to best practices in prevention of ORN and surgical management. No recommendation was possible for the utilization of leukocyte- and platelet-rich fibrin or photobiomodulation for prevention of ORN. The use of hyperbaric oxygen in prevention and management of ORN remains largely unjustified, with limited evidence to support its practice.Additional information is available at www.asco.org/head-neck-cancer-guidelines.
引用
- Peterson DE, Koyfman SA, Yarom N, et al. Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline. J Clin Oncol. 2024. PMID: 38691821. doi:10.1200/JCO.23.02750
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。